Literature DB >> 8663022

Octamer binding factors and their coactivator can activate the murine PU.1 (spi-1) promoter.

H Chen1, P Zhang, H S Radomska, C J Hetherington, D E Zhang, D G Tenen.   

Abstract

PU.1 (spi-1), a member of the Ets transcription factor family, is predominantly expressed in myeloid and B cells, activates many B cell and myeloid genes, and is critical for development of both of these lineages. Our previous studies (Chen, H. M., Ray-Gallet, D., Zhang, P., Hetherington, C. J., Gonzalez, D. A., Zhang, D.-E., Moreau-Gachelin, F., and Tenen, D. G. (1995) Oncogene 11, 1549-1560) demonstrate that the PU.1 promoter directs cell type-specific reporter gene expression in myeloid cell lines, and that PU.1 activates its own promoter in an autoregulatory loop. Here we show that the murine PU.1 promoter is also specifically and highly functional in B cell lines as well. Oct-1 and Oct-2 can bind specifically to a site at base pair -55 in vitro, and this site is specifically protected in B cells in vivo. We also demonstrate that two other sites contribute to promoter activity in B cells; an Sp1 binding site adjacent to the octamer site, and the PU.1 autoregulatory site. Finally, we show that the B cell coactivator OBF-1/Bob1/OCA-B is only expressed in B cells and not in myeloid cells, and that OBF-1/Bob1/OCA-B can transactivate the PU.1 promoter in HeLa and myeloid cells. This B cell restricted coactivator may be responsible for the B cell specific expression of PU.1 mediated by the octamer site.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8663022     DOI: 10.1074/jbc.271.26.15743

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

Review 1.  Macrophage-specific gene expression: current paradigms and future challenges.

Authors:  David R Greaves; Siamon Gordon
Journal:  Int J Hematol       Date:  2002-07       Impact factor: 2.490

Review 2.  Role of transcription factors C/EBPalpha and PU.1 in normal hematopoiesis and leukemia.

Authors:  Steffen Koschmieder; Frank Rosenbauer; Ulrich Steidl; Bronwyn M Owens; Daniel G Tenen
Journal:  Int J Hematol       Date:  2005-06       Impact factor: 2.490

Review 3.  POU domain transcription factors in embryonic development.

Authors:  G J Veenstra; P C van der Vliet; O H Destrée
Journal:  Mol Biol Rep       Date:  1997-08       Impact factor: 2.316

4.  Potential autoregulation of transcription factor PU.1 by an upstream regulatory element.

Authors:  Yutaka Okuno; Gang Huang; Frank Rosenbauer; Erica K Evans; Hanna S Radomska; Hiromi Iwasaki; Koichi Akashi; Francoise Moreau-Gachelin; Youlin Li; Pu Zhang; Berthold Göttgens; Daniel G Tenen
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

5.  ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression.

Authors:  Beatrice U Mueller; Thomas Pabst; José Fos; Vibor Petkovic; Martin F Fey; Norio Asou; Ulrich Buergi; Daniel G Tenen
Journal:  Blood       Date:  2005-12-13       Impact factor: 22.113

6.  Oncogene cooperativity in Friend erythroleukemia: erythropoietin receptor activation by the env gene of SFFV leads to transcriptional upregulation of PU.1, independent of SFFV proviral insertion.

Authors:  Iva Afrikanova; Ellen Yeh; David Bartos; Stephanie S Watowich; Gregory D Longmore
Journal:  Oncogene       Date:  2002-02-14       Impact factor: 9.867

7.  Graded repression of PU.1/Sfpi1 gene transcription by GATA factors regulates hematopoietic cell fate.

Authors:  Stella T Chou; Eugene Khandros; L Charles Bailey; Kim E Nichols; Christopher R Vakoc; Yu Yao; Zan Huang; John D Crispino; Ross C Hardison; Gerd A Blobel; Mitchell J Weiss
Journal:  Blood       Date:  2009-06-02       Impact factor: 22.113

8.  IRF8 regulates B-cell lineage specification, commitment, and differentiation.

Authors:  Hongsheng Wang; Chang Hoon Lee; Chenfeng Qi; Prafullakumar Tailor; Jianxun Feng; Sadia Abbasi; Toru Atsumi; Herbert C Morse
Journal:  Blood       Date:  2008-09-17       Impact factor: 22.113

9.  BOB.1/OBF.1 controls the balance of TH1 and TH2 immune responses.

Authors:  Cornelia Brunner; Anca Sindrilaru; Irute Girkontaite; Klaus-Dieter Fischer; Cord Sunderkötter; Thomas Wirth
Journal:  EMBO J       Date:  2007-06-14       Impact factor: 11.598

10.  Early chromatin unfolding by RUNX1: a molecular explanation for differential requirements during specification versus maintenance of the hematopoietic gene expression program.

Authors:  Maarten Hoogenkamp; Monika Lichtinger; Hanna Krysinska; Christophe Lancrin; Deborah Clarke; Andrew Williamson; Luca Mazzarella; Richard Ingram; Helle Jorgensen; Amanda Fisher; Daniel G Tenen; Valerie Kouskoff; Georges Lacaud; Constanze Bonifer
Journal:  Blood       Date:  2009-04-01       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.